These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 15104894)
1. Chimeric RNA and 2'-O, 4'-C-ethylene-bridged nucleic acids have stronger activity than phosphorothioate oligodeoxynucleotides in induction of exon 19 skipping in dystrophin mRNA. Yagi M; Takeshima Y; Surono A; Takagi M; Koizumi M; Matsuo M Oligonucleotides; 2004; 14(1):33-40. PubMed ID: 15104894 [TBL] [Abstract][Full Text] [Related]
2. Phosphorothioate modification of chimeric 2ยด-O-methyl RNA/ethylene-bridged nucleic acid oligonucleotides increases dystrophin exon 45 skipping capability and reduces cytotoxicity. Malueka RG; Dwianingsih EK; Yagi M; Lee T; Nishida A; Iijima K; Takeshima Y; Matsuo M Kobe J Med Sci; 2015 Feb; 60(4):E86-94. PubMed ID: 25791417 [TBL] [Abstract][Full Text] [Related]
3. Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon. Surono A; Van Khanh T; Takeshima Y; Wada H; Yagi M; Takagi M; Koizumi M; Matsuo M Hum Gene Ther; 2004 Aug; 15(8):749-57. PubMed ID: 15319032 [TBL] [Abstract][Full Text] [Related]
4. Design of 2'-O-Me RNA/ENA chimera oligonucleotides to induce exon skipping in dystrophin pre-mRNA. Takagi M; Yagi M; Ishibashi K; Takeshima Y; Surono A; Matsuo M; Koizumi M Nucleic Acids Symp Ser (Oxf); 2004; (48):297-8. PubMed ID: 17150596 [TBL] [Abstract][Full Text] [Related]
5. 2'-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 Skipping. Lee T; Awano H; Yagi M; Matsumoto M; Watanabe N; Goda R; Koizumi M; Takeshima Y; Matsuo M Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208626 [TBL] [Abstract][Full Text] [Related]
6. Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing. Takeshima Y; Yagi M; Matsuo M Methods Mol Biol; 2012; 867():131-41. PubMed ID: 22454059 [TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle. Takeshima Y; Yagi M; Wada H; Matsuo M Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206 [TBL] [Abstract][Full Text] [Related]
8. Renadirsen, a Novel 2'OMeRNA/ENA Ito K; Takakusa H; Kakuta M; Kanda A; Takagi N; Nagase H; Watanabe N; Asano D; Goda R; Masuda T; Nakamura A; Onishi Y; Onoda T; Koizumi M; Takeshima Y; Matsuo M; Takaishi K Curr Issues Mol Biol; 2021 Sep; 43(3):1267-1281. PubMed ID: 34698059 [TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide induced dystrophin exon 45 skipping at a low half-maximal effective concentration in a cell-free splicing system. Malueka RG; Yagi M; Awano H; Lee T; Dwianingsih EK; Nishida A; Takeshima Y; Matsuo M Nucleic Acid Ther; 2011 Oct; 21(5):347-53. PubMed ID: 21967521 [TBL] [Abstract][Full Text] [Related]
11. Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence. Pramono ZA; Takeshima Y; Alimsardjono H; Ishii A; Takeda S; Matsuo M Biochem Biophys Res Commun; 1996 Sep; 226(2):445-9. PubMed ID: 8806654 [TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091 [TBL] [Abstract][Full Text] [Related]